Conference Call with Dr. Lal Pathlabs Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Services company Dr. Lal Pathlabs announced Q1FY24 results: Revenue of Rs 541 crore in Q1FY24 compared to Rs 503 crore in Q1FY23, up 7.6% YoY Non-Covid Revenue increased by 9.7% to Rs 528 crore in Q1FY24 Normalised EBITDA margin (after adjustment for stock-based compensation & CSR) for Q1FY24 is 28.4% PAT margin for Q1FY24 is 15.4% Result PDF